Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
John Mekalanos
Harvard Medical School, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Matrivax Research and Developm
Other : Board of Directors
The research proposed is to evaluate the application of the PCMV technology to the development of killed whole cell oral vaccines. The company licenses the PCMV technology from Harvard and has provided preliminary results with vaccines to the Melakanos lab, although not the specific to the topic of the present research application. Additionally, the company may provide reagents that will be useful to the research. Finally, because the company has licensed the technology, Dr. Melakanos is a founder and sits on the board of directors and has an ownership interest in the company, his financial interest could directly and significantly affect the design, conduct or reporting of the proposed research.
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
There is a desperate need for effective countermeasures against emerging and re-emerging pathogens. Needed countermeasures include vaccines to prevent infection in at-risk populations and antibiotics to overcome potentially lethal treatment-resistant infections. This Center comprises two vaccine development projects and three antibacterial discovery projects organized around the theme of targeting the bacterial cell envelope. It also includes a sophisticated Discovery and Translational Services Core that will facilitate the translation of academic knowledge into effective countermeasures against bacterial pathogens.
Filed on January 22, 2014.
Tell us what you know about John Mekalanos's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “John Mekalanos”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| John Mekalanos | Harvard Medical School | Conflict of Interest | Matrivax Research and Developm | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.